Cervical cancer: Effect of glandular cell type on prognosis, treatment, and survival

Obstetrics and Gynecology

Volumn 101, Issue 1, 2003, Pages 38-45

  Davy, Margaret L J ^a,b,c,d   Dodd, Tom J ^a,b,c,d   Luke, Colin G ^a,b,c,d   Roder, David M ^a,b,c,d  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c DEPARTMENT OF HUMAN SERVICES   (Australia)

^d Anti Cancer Found of S Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER GRADING; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CELL TYPE; CLEAR CELL CARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FATALITY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0037217842     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02275-5     Document Type: Article

References (32)

1. Cervical screening in Australia 1998-1999. 2001;Australian Institute of Health and Welfare, Canberra, Australia.
2. Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977 to 2000. Incidence and mortality, 2000. 2001;83-90 Openbook Publishing House, Adelaide, Australia.
3. Liu S., Semenciw R., Mao Y. Cervical cancer The increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women . CMAJ. 164:2001;1151-1152.
4. Bergstrom R., Sparen P., Adami H.O. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 81:1999;159-166.
5. Zheng T., Holford T.R., Ma Z., Chen Y., Liu W., Ward B.A., et al. The continuing increase in adenocarcinoma of the uterine cervix A birth cohort phenomenon . Int J Epidemiol. 25:1996;252-258.
6. Wharton V. Neoplasms of the cervix. Holland J.F., Frei E., Bast R.C., Kufe D.W., Morton D.L., Weichselbaum R.R. Cancer medicine. Vol II. 4th ed. 1995;2227-2261 Williams and Wilkins, Toronto.
7. Sasieni P., Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet. 357:2001;1490-1493.
8. Kjaer S.K., Brinton L.A. Adenocarcinomas of the uterine cervix The epidemiology of an increasing problem . Epidemiol Rev. 15:1993;486-498.
9. Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977-1999. Incidence and mortality, 1999. 2000;19-269 Openbook Publishing House, Adelaide, Australia.
10. Cannistra S.A., Niloff J.M. Cancer of the uterine cervix. N Engl J Med. 334:1996;1030-1038.
11. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes A Gynecologic Oncology Group and Southwest Oncology Group study . J Clin Oncol. 17:1999;1339-1348.
12. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 340:1999;1154-1161.
13. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 340:1999;1144-1153.
14. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:1999;1137-1143.
15. Thomas G.M. Improved treatment for cervical cancer - concurrent chemotherapy and radiotherapy. N Engl J Med. 340:1999;1198-1200.
16. Zhang M., Cai S., Shi D. The comparison of radiosensitivity between uterine carcinoma and adenocarcinoma. Chung Hua Fu Chan Ko Tsa Chih. 33:1998;611-613.
17. Fritz A., Percy C., Jack A., Kanagaratnam S., Sobin L., Parkin D.M., et al. International classification of disease for oncology. 3rd ed. 2000;World Health Organization, Geneva.
18. TNM classification of malignant tumours. 4th ed. 1987;Springer Verlag, Berlin.
19. Hahn Johnston C., Richards L. Standards of the Commission on Cancer, Volume 2. Registry operations and data standards (ROADS). 1998;Commission on Cancer, Chicago.
20. Bonett A., Roder D., Esterman A. Cancer case-survival rates for South Australia A comparison with US rates and a preliminary investigation of time trends . Med J Aust. 148:1988;556-559.
21. StataCorp. Stata Statistical Software: Release 6.0. College Station, Texas: StataCorp.
22. South Australian Cancer Registry. Epidemiology of Cancer in South Australia. Incidence, Mortality and Survival, 1977 to 1996. Incidence and Mortality, 1996. Adelaide, Australia: Openbook Publishing House, 1997:11-9, 21-8.
23. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford, United Kingdom: Blackwell Scientific Publications, 1987:387, 411-6, 428-32, 436-7.
24. Hosmer D.W., Lemeshow S. Applied logistic regression. 1989;132-133 John Wiley and Sons, New York.
25. Epidemiology of cancer in South Australia. Incidence mortality and survival, 1977 to 1993. Incidence and mortality 1993. 1994;Openbook Publishing House, Adelaide, Australia.
26. Zaino R.J., Ward S., Delgado G., Bundy B., Gore H., Fetter G., et al. Histological predictors of the behaviour of surgically treated stage 1B squamous cell carcinoma of the cervix. A Gynaecological Oncology Group Study. Cancer. 69:1992;1750-1758.
27. Ishikawa H., Nakanishi T., Inoue T., Kuzuya K. Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol. 73:1999;42-46.
28. Costa M.J., McIlnay K.R., Trelford J. Cervical carcinoma with glandular differentiation; histological evaluation predicts disease recurrence in clinical stage I or II patients. Hum Pathol. 26:1995;829-837.
29. Kristensen G.B., Abeler V.M., Risberg B., Trope C., Byrne M. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol. 74:1999;245-251.
30. Cervical cancer screening in Australia Options for change. Australian Institute of Health prevention program evaluation series no. 2 . 1990;Australian Government Publishing Service, Canberra, Australia.
31. Mitchell H., Medley G., Gordon I., Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix No strong evidence of benefit . Br J Cancer. 71:1995;894-897.
32. Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977 to 1997. Incidence and mortality, 1997. 1998;77-90 Openbook Publishing House, Adelaide, Australia.